Inactive

The Food & Drug Administration (FDA) intends to award on a sole source basis to: Commonwealth of the Northern Mariana Islands Department of Commerce Caller Box 10007 Chalan Kanoa, Saipan Northern Mari... The Food & Drug Administration (FDA) intends to award on a sole source basis to: Commonwealth of the Northern Mariana Islands Department of Commerce Caller Box 10007 Chalan Kanoa, Saipan Northern Mariana Islands, 96950 The FDA intends to award a one (1) year and three (3) twelve-month option year Contract. The Food and Drug Administration (FDA) intends to award a contract to assist in inspecting retail establishments that sell cigarettes and/or smokeless tobacco products and in surveillance of other entities that fall under the scope of the Tobacco Control Act and the provisions that will be cited in the request for proposal (RFP). All interested parties must be an agency or subdivision of a state, territory, local, or tribal government that has the power to create, enforce, or administer rules or policies that govern the conduct of individuals or other private entities such as small businesses. The proposed contract action is for services for which the Government intends to solicit and negotiate with ONLY state organizations under the authority of 41 U.S.C. 3304(a)(5). This notice is issued for informational purposes and is not a request for competitive proposals. Any interested party shall submit a capabilities statement and/or a statement of intent to include a description of your legal authority, organizational capability, and staffing capacity to conduct tobacco compliance check inspections, a point of contact, official agency name, address, and valid DUNS number. It shall not exceed 5 double spaced pages. The solicitation will be available in May/June 2021 on the Beta.Sam.gov website at www.BetaSam.gov. It is the offerors responsibility to monitor the Beta.Sam website for the release of the solicitation and amendments. Responses to this notice must be sent via email to Daytona Philpotts at Daytona.philpotts@fda.hhs.gov by 11:59 pm Eastern Standard Time, April 17, 2020 and reference Presolicitation Number 75F40121R00019 in the subject line of your response.